ONTOLOGY REPORT - ANNOTATIONS
| Term: | hydroxyurea |
|
| Accession: | CHEBI:44423
|
browse the term
|
| Definition: | An urea that has formula CH4N2O2. |
| Synonyms: | related_synonym: | CH4N2O2; Hydroxycarbamid; Hydroxycarbamide; Hydroxyharnstoff; InChI=1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4); InChIKey=VSNHCAURESNICA-UHFFFAOYSA-N; N-HYDROXYUREA; N-carbamoylhydroxylamine; NC(=O)NO; carbamohydroxamic acid; carbamohydroximic acid; carbamoyl oxime; carbamyl hydroxamate; hydrea; oxyurea |
| | alt_id: | CHEBI:44420; CHEBI:5816 |
| | xref_casrn: | 127-07-1 |
| | xref: | ChEMBL:104730 "ChEMBL COMPOUND"; ChemIDplus:127-07-1 "CAS Registry Number"; ChemIDplus:1741548 "Beilstein Registry Number"; DrugBank:DB01005 "DrugBank"; Gmelin:130423 "Gmelin Registry Number"; KEGG COMPOUND:127-07-1 "CAS Registry Number"; KEGG COMPOUND:C07044 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D006918 |
| | xref: | PDBeChem:NHY "PDBeChem"; Wikipedia:Hydroxyurea "Wikipedia" |
|
|
hydroxyurea
|
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
multiple interactions |
ISO |
1 |
185,970,658 |
185,974,615 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
multiple interactions |
ISO |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Atp6v1f |
ATPase, H transporting, lysosomal V1 subunit F |
|
increases mutagenesis |
ISO |
4 |
56,347,184 |
56,350,085 |
RGD:6480464 |
CTD |
| G |
Atr |
ataxia telangiectasia and Rad3 related |
|
multiple interactions |
ISO |
8 |
100,936,342 |
101,014,881 |
RGD:6480464 |
CTD |
| G |
Atr |
ataxia telangiectasia and Rad3 related |
|
multiple interactions |
ISO |
8 |
100,936,342 |
101,014,881 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases response to substance |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Blm |
Bloom syndrome, RecQ helicase-like |
|
increases expression |
ISO |
1 |
136,271,573 |
136,358,077 |
RGD:6480464 |
CTD |
| G |
Bmi1 |
Bmi1 polycomb ring finger oncogene |
|
decreases expression |
ISO |
17 |
92,784,216 |
92,787,947 |
RGD:6480464 |
CTD |
| G |
Bora |
bora, aurora kinase A activator |
|
decreases expression |
ISO |
15 |
82,829,209 |
82,852,061 |
RGD:6480464 |
CTD |
| G |
Bpnt1 |
3'(2'), 5'-bisphosphate nucleotidase 1 |
|
increases mutagenesis |
ISO |
13 |
101,340,544 |
101,367,549 |
RGD:6480464 |
CTD |
| G |
Bscl2 |
Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
|
increases expression |
ISO |
1 |
211,509,675 |
211,518,963 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
increases expression |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
increases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
decreases expression |
ISO |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
ISO |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Ccng2 |
cyclin G2 |
|
increases expression |
ISO |
14 |
16,338,132 |
16,346,628 |
RGD:6480464 |
CTD |
| G |
Cdc25a |
cell division cycle 25A |
|
increases expression |
ISO |
8 |
114,237,704 |
114,255,971 |
RGD:6480464 |
CTD |
| G |
Cdca8 |
cell division cycle associated 8 |
|
decreases expression |
ISO |
5 |
144,251,164 |
144,276,352 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk5rap1 |
CDK5 regulatory subunit associated protein 1 |
|
increases mutagenesis |
ISO |
3 |
144,803,213 |
144,840,056 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
increases expression |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Chchd3 |
coiled-coil-helix-coiled-coil-helix domain containing 3 |
|
decreases expression |
ISO |
4 |
59,891,615 |
60,170,903 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
multiple interactions |
ISO |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
decreases expression |
ISO |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Cideb |
cell death-inducing DFFA-like effector b |
|
decreases expression |
ISO |
15 |
33,916,472 |
33,920,872 |
RGD:6480464 |
CTD |
| G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
|
decreases expression |
ISO |
17 |
19,423,502 |
19,429,451 |
RGD:6480464 |
CTD |
| G |
Cpb2 |
carboxypeptidase B2 (plasma) |
|
decreases expression |
ISO |
15 |
56,104,920 |
56,154,321 |
RGD:6480464 |
CTD |
| G |
Cradd |
CASP2 and RIPK1 domain containing adaptor with death domain |
|
increases mutagenesis |
ISO |
7 |
32,504,279 |
32,517,581 |
RGD:6480464 |
CTD |
| G |
Cxcr1 |
chemokine (C-X-C motif) receptor 1 |
|
increases mutagenesis |
ISO |
9 |
73,510,488 |
73,511,537 |
RGD:6480464 |
CTD |
| G |
Dclre1c |
DNA cross-link repair 1C |
|
increases response to substance |
ISO |
17 |
85,896,581 |
85,928,644 |
RGD:6480464 |
CTD |
| G |
Ddb2 |
damage specific DNA binding protein 2 |
|
increases expression |
ISO |
3 |
75,568,487 |
75,591,428 |
RGD:6480464 |
CTD |
| G |
Dlgap1 |
discs, large (Drosophila) homolog-associated protein 1 |
|
increases mutagenesis |
ISO |
9 |
109,455,911 |
110,018,738 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
affects response to substance |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dym |
dymeclin |
|
increases mutagenesis |
ISO |
18 |
71,889,053 |
72,188,251 |
RGD:6480464 |
CTD |
| G |
Ech1 |
enoyl CoA hydratase 1, peroxisomal |
|
increases mutagenesis |
ISO |
1 |
83,932,720 |
83,938,918 |
RGD:6480464 |
CTD |
| G |
Edn3 |
endothelin 3 |
|
decreases expression |
ISO |
3 |
166,491,368 |
166,514,051 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
increases expression |
ISO |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Ercc5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 |
|
increases expression |
ISO |
9 |
43,248,023 |
43,293,196 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fkbp3 |
FK506 binding protein 3 |
|
increases expression |
ISO |
6 |
86,410,859 |
86,422,588 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Galnt16 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
|
increases mutagenesis |
ISO |
6 |
104,285,081 |
104,366,257 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
multiple interactions |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
affects localization |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
decreases activity |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Got2 |
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) |
|
multiple interactions |
ISO |
19 |
9,629,687 |
9,655,336 |
RGD:6480464 |
CTD |
| G |
Grb14 |
growth factor receptor bound protein 14 |
|
increases mutagenesis |
ISO |
3 |
46,832,380 |
46,952,670 |
RGD:6480464 |
CTD |
| G |
Hdac2 |
histone deacetylase 2 |
|
multiple interactions |
ISO |
20 |
41,162,093 |
41,186,492 |
RGD:6480464 |
CTD |
| G |
Hesx1 |
HESX homeobox 1 |
|
increases mutagenesis |
ISO |
16 |
2,255,128 |
2,257,233 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
increases expression |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
increases expression |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
affects expression |
ISO |
10 |
39,093,512 |
39,096,069 |
RGD:6480464 |
CTD |
| G |
Kif3b |
kinesin family member 3B |
|
increases mutagenesis |
ISO |
3 |
143,642,175 |
143,681,902 |
RGD:6480464 |
CTD |
| G |
Kpna2 |
karyopherin alpha 2 |
|
decreases expression |
ISO |
10 |
96,342,214 |
96,352,613 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
decreases expression |
ISO |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
LOC100359600 |
karyopherin alpha 2-like |
|
decreases expression |
ISO |
6 |
10,523,393 |
10,524,982 |
RGD:6480464 |
CTD |
| G |
Mad2l1 |
MAD2 mitotic arrest deficient-like 1 (yeast) |
|
decreases expression |
ISO |
4 |
96,380,039 |
96,386,042 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
decreases phosphorylation |
EXP |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
affects expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mecom |
MDS1 and EVI1 complex locus |
|
increases expression |
ISO |
2 |
114,814,409 |
114,882,676 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
increases expression |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mpg |
N-methylpurine-DNA glycosylase |
|
increases expression |
ISO |
10 |
15,643,334 |
15,649,561 |
RGD:6480464 |
CTD |
| G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
decreases expression |
ISO |
6 |
51,129,160 |
51,166,514 |
RGD:6480464 |
CTD |
| G |
Nek3 |
NIMA-related kinase 3 |
|
decreases expression |
ISO |
16 |
74,524,839 |
74,547,785 |
RGD:6480464 |
CTD |
| G |
Neurod4 |
neuronal differentiation 4 |
|
decreases expression |
ISO |
7 |
8,534,957 |
8,547,130 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases expression |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nudt12 |
nudix (nucleoside diphosphate linked moiety X)-type motif 12 |
|
increases expression |
ISO |
9 |
97,551,943 |
97,565,919 |
RGD:6480464 |
CTD |
| G |
Nus1 |
nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
20 |
31,143,886 |
31,170,668 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
decreases expression |
ISO |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Ppp1r12a |
protein phosphatase 1, regulatory subunit 12A |
|
decreases expression |
ISO |
7 |
46,876,552 |
46,986,022 |
RGD:6480464 |
CTD |
| G |
Prc1 |
protein regulator of cytokinesis 1 |
|
decreases expression |
ISO |
1 |
136,112,674 |
136,133,720 |
RGD:6480464 |
CTD |
| G |
Prl2b1 |
Prolactin family 2, subfamily b, member 1 |
|
increases expression |
ISO |
17 |
44,180,979 |
44,188,002 |
RGD:6480464 |
CTD |
| G |
Prune |
prune exopolyphosphatase |
|
increases mutagenesis |
ISO |
2 |
190,165,356 |
190,192,807 |
RGD:6480464 |
CTD |
| G |
Psip1 |
PC4 and SFRS1 interacting protein 1 |
|
decreases expression |
ISO |
5 |
102,304,948 |
102,336,608 |
RGD:6480464 |
CTD |
| G |
Psrc1 |
proline/serine-rich coiled-coil 1 |
|
decreases expression |
ISO |
2 |
203,952,299 |
203,956,742 |
RGD:6480464 |
CTD |
| G |
Rab34 |
RAB34, member RAS oncogene family |
|
increases expression |
ISO |
10 |
64,443,111 |
64,447,315 |
RGD:6480464 |
CTD |
| G |
Rad23a |
RAD23 homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
19 |
24,971,070 |
24,976,901 |
RGD:6480464 |
CTD |
| G |
Ran |
RAN, member RAS oncogene family |
|
decreases expression |
ISO |
12 |
28,736,786 |
28,739,921 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
increases mutagenesis |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rbm4 |
RNA binding motif protein 4 |
|
increases mutagenesis |
ISO |
1 |
207,394,470 |
207,403,393 |
RGD:6480464 |
CTD |
| G |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
|
increases mutagenesis |
ISO |
7 |
20,976,369 |
21,052,088 |
RGD:6480464 |
CTD |
| G |
Rnf19a |
ring finger protein 19A, E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
7 |
71,763,837 |
71,803,435 |
RGD:6480464 |
CTD |
| G |
Rpl22l1 |
ribosomal protein L22 like 1 |
|
decreases expression |
ISO |
2 |
116,168,790 |
116,170,726 |
RGD:6480464 |
CTD |
| G |
Rras |
related RAS viral (r-ras) oncogene homolog |
|
increases expression |
ISO |
1 |
95,490,730 |
95,495,462 |
RGD:6480464 |
CTD |
| G |
Rrm2b |
ribonucleotide reductase M2 B (TP53 inducible) |
|
increases expression |
ISO |
7 |
73,432,161 |
73,459,541 |
RGD:6480464 |
CTD |
| G |
Runx1 |
runt-related transcription factor 1 |
|
increases expression |
ISO |
11 |
32,623,461 |
32,725,404 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
increases expression |
ISO |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Slc14a1 |
solute carrier family 14 (urea transporter), member 1 |
|
affects transport |
ISO |
18 |
75,024,200 |
75,048,481 |
RGD:6480464 |
CTD |
| G |
Slc16a12 |
solute carrier family 16, member 12 (monocarboxylic acid transporter 12) |
|
increases mutagenesis |
ISO |
1 |
238,643,040 |
238,665,699 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
multiple interactions |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Spink4 |
serine peptidase inhibitor, Kazal type 4 |
|
increases mutagenesis |
ISO |
5 |
58,314,305 |
58,325,973 |
RGD:6480464 |
CTD |
| G |
Srxn1 |
sulfiredoxin 1 |
|
increases expression |
ISO |
3 |
142,457,352 |
142,462,725 |
RGD:6480464 |
CTD |
| G |
Tbpl1 |
TBP-like 1 |
|
affects localization |
ISO |
1 |
23,295,515 |
23,320,298 |
RGD:6480464 |
CTD |
| G |
Tmem69 |
transmembrane protein 69 |
|
increases mutagenesis |
ISO |
5 |
136,831,040 |
136,834,619 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Top1 |
topoisomerase (DNA) I |
|
decreases expression |
ISO |
3 |
151,428,931 |
151,512,884 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tpp2 |
tripeptidyl peptidase II |
|
affects localization |
ISO |
9 |
42,984,834 |
43,066,195 |
RGD:6480464 |
CTD |
| G |
Tpp2 |
tripeptidyl peptidase II |
|
affects localization |
ISO |
9 |
42,984,834 |
43,066,195 |
RGD:6480464 |
CTD |
| G |
Tradd |
TNFRSF1A-associated via death domain |
|
multiple interactions |
ISO |
19 |
35,073,150 |
35,075,251 |
RGD:6480464 |
CTD |
| G |
Trg |
T cell receptor gamma locus |
|
increases mutagenesis |
ISO |
17 |
53,496,412 |
53,528,047 |
RGD:6480464 |
CTD |
| G |
Triap1 |
TP53 regulated inhibitor of apoptosis 1 |
|
increases expression |
ISO |
12 |
42,535,655 |
42,538,148 |
RGD:6480464 |
CTD |
| G |
Ubac2 |
UBA domain containing 2 |
|
increases mutagenesis |
ISO |
15 |
107,009,509 |
107,125,419 |
RGD:6480464 |
CTD |
| G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
|
decreases expression |
ISO |
3 |
155,800,357 |
155,802,757 |
RGD:6480464 |
CTD |
| G |
Xpc |
xeroderma pigmentosum, complementation group C |
|
increases expression |
ISO |
4 |
125,672,674 |
125,699,925 |
RGD:6480464 |
CTD |
| G |
Xrcc4 |
X-ray repair complementing defective repair in Chinese hamster cells 4 |
|
decreases response to substance |
ISO |
2 |
19,904,490 |
20,158,358 |
RGD:6480464 |
CTD |
| G |
Xrcc5 |
X-ray repair complementing defective repair in Chinese hamster cells 5 |
|
decreases expression |
ISO |
9 |
71,472,459 |
71,581,936 |
RGD:6480464 |
CTD |
| G |
Xrcc5 |
X-ray repair complementing defective repair in Chinese hamster cells 5 |
|
increases mutagenesis |
ISO |
9 |
71,472,459 |
71,581,936 |
RGD:6480464 |
CTD |
| G |
Zfp385a |
zinc finger protein 385A |
|
increases expression |
ISO |
7 |
142,222,824 |
142,250,176 |
RGD:6480464 |
CTD |
| G |
Zfp52 |
zinc finger protein 52 |
|
decreases expression |
ISO |
1 |
59,540,774 |
59,568,607 |
RGD:6480464 |
CTD |
Term paths to the root
|